Combination of ertapenem and penicillin M or cefazolin in the treatment of methicillin-susceptible Staphylococcus aureus bacteremia: multicenter case series Dual therapy (DT) combining penicillin M or cefazolin with ertapenem has been proposed as treatment of complicated Staphylococcus aureus bacteremia (S…

[Publication] The article "Combination of #ertapenem and penicillin M or #cefazolin in the treatment of methicillin-susceptible Staphylococcus aureus bacteremia: multicenter case series" is now available.

www.sciencedirect.com/science/arti...

#IDsky #CombinationTherapy #StaphylococcusAureus

Saxagliptin and vitamin D preserve β-cell function in autoimmune diabetes
Combination therapy demonstrates β-cell protection in adult-onset autoimmune diabetes.
doi.org/10.1038/s413...
#AutoimmuneDiabetes #BetaCellFunction #CombinationTherapy #ClinicalDiabetes

Clinical outcomes of treatments for patients with refractory metastatic colorectal cancer: a systematic literature review and network meta-analysis
@tamedoncol.bsky.social
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#cancertreatment #combinationtherapy #oncology #openaccess

Gut bacteria molecule boosts lung cancer immunotherapy – BioNews Central Researchers have discovered a small compound produced naturally by gut bacteria that doubled the response to lung cancer immunotherapy in mice and can now be made into a drug for testing in humans. ...

Researchers have discovered a #SmallMolecule produced naturally by #GutBacteria that doubled the response to #LungCancer #immunotherapy in mice and can now be made into a #drug for testing in humans.
#LungCancerTreatment #CombinationTherapy #MicrobialMetabolite

#ONCOnews #OncoAlert #OncEd #mCRC #Oncology #ASCO #GI26 #CombinationTherapy

DAY Two of #CFS25 🚨
Dr. Vincent Xu breaks down the latest in combination therapy for Renal Cell Carcinoma (RCC). PD-1 based doublets are the standard of care for 1st-line metastatic disease. #KidneyCancer #RCC #CombinationTherapy

HCP's Register FOR FREE 👉 (USE CODE: ONCOALERT ) buff.ly/OWT0

Synapse: Your Connection to our MSK Authors
Meet: Paul A Calder
Research Focus: SKI Pediatrics; Sr Research Assistant

synapse.mskcc.org/synapse/work...

#DrugDiscovery #CombinationTherapy #BayesianModeling #ActiveLearning #AIInBiotech #CancerResearch #PrecisionOncology #SystemsPharmacology

Capivasertib/Fulvestrant in patients with HR+, HER2-low or HER2-negative locally advanced or metastatic breast cancer
@tamedoncol.bsky.social
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#medicaloncology #combinationtherapy #targetedtherapy #oncosky #medsky #openaccess

Combination Therapy Drug Market Forecasted to Surpass USD 120.0 Billion by 2032, Driven by a Strong 3.17% CAGR - Industry Today Combination Therapy Drug Market Industry is expected to grow from 93.51(USD Billion) in 2024 to 120.0 (USD Billion) by 2032.

💊🧪 Combination Therapy Drug Market crossing $120.0B by 2032! Multi-drug regimens = better outcomes!
👉 #CombinationTherapy #PharmaTrends #HealthcareGrowth 💉📈

industrytoday.co.uk/health_and_s...

Radiation therapy overcomes immunotherapy resistance in some cancers – BioNews Central New research shows that radiation therapy can make certain tumors that resist immunotherapy respond to treatment, leading to improved outcomes for patients. ...

New research shows that #RadiationTherapy can make certain #tumors that resist #immunotherapy respond to treatment, leading to improved #PatientOutcomes.
#ImmunotherapyResistance #Radiotherapy #CombinationTherapy 

Safety, efficacy, and cardiovascular benefits of combination therapy with SGLT-2 inhibitors and GLP-1 receptor agonists in patients with diabetes mellitus: a systematic review and meta-analysis of ran... Background The potential benefits and risks of combination therapy with sodium-glucose co-transporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) versus monotherap...

#CombinationTherapy with SGLT-2 inhibitors and GLP-1 receptor agonists improves heart and #MetabolicOutcomes in type 2 #diabetes, reducing #HeartFailure #hospitalizations and major #CardiovascularEvents, with some increased GI side effects. #Diabetes dmsjournal.biomedcentral.com/articles/10....

Cancer-fighting herpes virus combined with immunotherapy shown to be an effective treatment for some advanced melanoma – BioNews Central A genetically engineered herpes simplex virus, combined with immunotherapy, reduces or eliminates tumors in one-third of patients with advanced melanoma. ...

A #GeneticallyEngineered #HerpesSimplexVirus, combined with #immunotherapy, reduces or eliminates #tumors in one-third of patients with #AdvancedMelanoma.
#Melanoma #OncolyticImmunotherapy #Nivolumab #CombinationTherapy

Teva and Fosun Pharma partner on early-stage oncology drug - PharmaTimes The candidate is being evaluated as both a monotherapy and in combination pembrolizumab

#drugdevelopment #Oncology #FosunPharma #TEV56278 #Teva #monotherapy #combinationtherapy #pembrolizumab #clinicaldatageneration #antiPD1IL2ATTENUKINEtherapy #antitumourTcellactivity #MerckandCo #MSD #enhancedTcellinfiltration #immunememory #preclinicalstudies
pharmatimes.com/news/teva-an...

Innovative treatment achieves complete long-term remission without surgery in 46 percent of advanced liver cancer patients – BioNews Central A study has shown that combined locoregional therapy and immunotherapy provides a safe, effective, and lasting treatment response for patients with advanced liver cancer, identifying key factors linked to complete response. ...

A study has shown that combined #LocoregionalTherapy and #immunotherapy provides a safe, effective, and lasting #TreatmentResponse for patients with #AdvancedLiverCancer, identifying key factors linked to #CompleteResponse.
#LiverCancer #LiverCancerTreatment #CombinationTherapy

Combination therapy extends lifespan in mice – BioNews Central A combination therapy of trametinib and rapamycin extends the lifespan of mice by about 30 percent, improves their health in old age by reducing chronic inflammation, and delays the onset of cancer. ...

A #CombinationTherapy of #trametinib and #rapamycin extends the #lifespan of mice by about 30 percent, improves their health in old age by reducing #ChronicInflammation, and delays the onset of #cancer.
#LifespanExtension #Healthspan

Drug targets identified for pancreatic cancer – BioNews Central Simultaneous disruption of lipid metabolism and KRAS-MAPK signaling eliminates pancreatic cancer tumors in preclinical human and mouse models. ...

Simultaneous disruption of #LipidMetabolism and #KRAS - #MAPK signaling eliminates #PancreaticCancer #tumors in preclinical human and mouse models.
#TherapeuticTargets #CombinationTherapy

Reprogramming cancer cells to treat acute myelogenous leukemia – BioNews Central A new combination therapy alters gene activity to reduce stem cell-like traits and promote cell differentiation, offering potential therapeutic benefits for acute myelogenous leukemia (AML). ...

A new #CombinationTherapy alters #GeneActivity to reduce #StemCell -like traits and promote #CellDifferentiation, offering potential therapeutic benefits for #AcuteMyelogenousLeukemia (#AML).

💡 When assessing the combination of preventative SAAP-148 and post-infection halicin treatment in these cultures, I also found that SAAP-148 and halicin only acted synergistically in skin but not in lung tissue (still beneficial though!) #CombinationTherapy #SequentialTreatment

First daily pill for endometriosis approved for NHS use

#NICE #NICEnews #womenshealth #endometriosis #NHSuse #hometreatment #combinationtherapy #relugolixestradiolnorethisterone #relugolixcombinationtherapy #Ryeqo #GedeonRichter #endometriosismanagement #NICEevaluationprocess #routineNHScommissioning
www.nice.org.uk/news/article...

Mitazalimab shows promising survival rates in cancer study - PharmaTimes Updated data from phase 2 study reveals survival benefit

#oncology #Mitazalimab #survivalrates #phase2study #survivalbenefit #AlligatorBioscience #phase2clincialtrial #OPTIMIZE1study #combinationtherapy #mFOLFIRINOX #metastaticpancreaticcancer #pancreaticcancer #pancreaticcancerpatients #clinicaltrials #drugdevelopment
pharmatimes.com/news/mitazal...

Finerenone: Do we need another treatment for #CKD in #T2D ❓

🔹 Reduces CKD progression by 23% & CV events by 14% (FIDELITY analysis).

🔸 Complements RASi & SGLT2i therapies, offering comprehensive cardio-renal protection.

❗️A new pillar in T2D & CKD Mx #CombinationTherapy.

🔗 ggdocs.co/nqip3c

Eric K. Singhi: Does MARIPOSA study update simplify first-line treatment decisions? - OncoDaily Eric K. Singhi: Does MARIPOSA study update simplify first-line treatment decisions? / cancer, combination therapy, Eric K. Singhi, MARIPOSA study, MD Anderson

Does MARIPOSA study update simplify first-line treatment decisions? - Eric K. Singhi
@lungoncdoc.bsky.social
@mdanderson.bsky.social

oncodaily.com/insight/eric...

#Cancer #CombinationTherapy #MARIPOSAstudy #OncoDaily #Oncology #Osimertinib #Medicine #Health

#PIBDRD25 Day 2, Session 7 (April 11, 2025) at
@childrensnational.bsky.social in Washington DC‼️
#PediatricDrugDevelopment #RefractoryIBD #CombinationTherapy #BoneHealth #AutoimmunePancreatitis #BodyComposition #Pancreatitis #SexDifferences #SexInScience #IBD

Ceftazidime, a third-generation cephalosporin, showed reduced MIC from 32 μg/mL to 16 μg/mL when combined with hydroquinine against MDR P. aeruginosa. This multitarget approach enhances efficacy. What other combinations could lead to similar synergistic effects? #CombinationTherapy #Synergy

With the AEROECLIPSE® II BAN® Nebulizer and Aerobika® device in Combination Therapy, you can save time on treatments and spend more of it on what really matters – making memories together.
www.monaghanmed.com/product/comb...

#CombinationTherapy #TimeTogether #TeamMonaghan